Kelly A. Demerino
Corporate Officer/Principal bei NUVO PHARMACEUTICALS INC.
Aktive Positionen von Kelly A. Demerino
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NUVO PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.01.2021 | - |
Comptroller/Controller/Auditor | 01.01.2019 | 01.01.2020 | |
Director of Finance/CFO | 01.01.2020 | 01.01.2021 |
Karriereverlauf von Kelly A. Demerino
Ausbildung von Kelly A. Demerino
Mount Allison University | Undergraduate Degree |
Statistik
International
Kanada | 3 |
Operativ
Comptroller/Controller/Auditor | 1 |
Director of Finance/CFO | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Nuvo Pharmaceuticals, Inc.
Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
- Börse
- Insiders
- Kelly A. Demerino
- Erfahrung